Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. Vergès (Grenoble, France). Hypoxic conditioning as a new therapeutic modality. International Congress 2019 – State of the art session: Sleep and breathing disorders

Member's Comments

No comment yet.

Related content which might interest you: A new definition of multimodality treatment Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts Year: 2016 Optimizing the target therapy development Source: ERS Research Seminar Year: 2015 Reversing glucocorticoid resistance as a new therapeutic strategy Source: Annual Congress 2012 - The promise of new drugs for treating asthma and COPD Year: 2012 Safety and effectiveness of flexible endobronchial cryotherapy as a diagnostic and concurrently therapeutic modality Source: Annual Congress 2010 - Airway patency: the role of interventional bronchoscopy Year: 2010 Regional chemotherapy: a new combined modality approach Source: Annual Congress 2004 - Lung metastases Year: 2004 Old and new therapeutic options in BOS Source: School Course 2012 - Lung Transplantation Year: 2012 Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014 From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Effect of long-term imatinib treatment in a severe preclinical PAH rat model: An insight into pulmonary perfusion using a novel casting method Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020 Current and future preventive and treatment strategies in CLAD Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation Year: 2015 Combined modality treatment for NSCLC Source: Annual Congress 2007 - PG7 - Thoracic oncology: nonsmall cell lung cancer Year: 2007 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma Source: Eur Respir J, 53 (2) 1802444; 10.1183/13993003.02444-2018 Year: 2019 Multimodal therapeutic approach for locally advanced NSCLC in everyday practice Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Hypoxic challenge testing in motor neurone disease Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015 Refractory chylothorax: Midodrine as a novel therapeutic option Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021